Pharma Search & Evaluation Panel: Understanding the Role of In Vivo Therapeutic in Shifting Investment & Acquisition Strategies

• Assessing how investors and pharma teams are integrating in vivo approaches into evolving pipeline and portfolio strategies
• Identifying the evidence and value inflection points shaping investment decisions for in vivo cell and gene therapy programs
• Aligning milestones, data packages and deal structures with shifting search, evaluation and investment priorities across the sector

Speakers:

Kevin Cognetti

Vice President of Corporate Strategy

Kite Pharma

Arpita Maiti

Vice President - Search & Evaluation Immunology, Specialty, Eye Care, Platform Technologies

Abbvie

Brian Zhou

Associate Director - Genetic Medicine Search & Evaluation

Eli Lilly

Deanna Mele

senior director BD

AstraZeneca